Objective: Patients with HERG-associated long QT syndrome typically develop tachyarrhythmias during physical or emotional stress. Previous studies have revealed that activation of the beta-adrenergic system and consecutive elevation of the intracellular cAMP concentration regulate HERG channels via protein kinase A-mediated phosphorylation of the channel protein and via direct interaction with the cAMP binding site of HERG. In contrast, the influence of the alpha-adrenergic signal transduction cascade on HERG currents as suggested by recent reports is less well understood. The aim of the present study was to elucidate the biochemical pathways of the protein kinase C (PKC)-dependent regulation of HERG currents. Methods: HERG channels were heterologously expressed in Xenopus laevis oocytes, and currents were measured using the two-microelectrode voltage clamp technique. Results: Application of the phorbol ester PMA, an unspecific protein kinase activator, shifted the voltage dependence of HERG activation towards more positive potentials. This effect could be mimicked by activation of conventional PKC isoforms with thymeleatoxin. Coexpression of HERG with the beta-subunits minK or hMiRP1 did not alter the effect of PMA. Specific inhibition of PKC abolished the PMA-induced activation shift, suggesting that PKC is required within the regulatory mechanism. The PMA-induced effect could still be observed when the PKC-dependent phosphorylation sites in HERG were deleted by mutagenesis. Cytoskeletal proteins such as actin filaments or microtubules did not affect the HERG activation shift. Conclusion: In addition to the known effects of PKA and cAMP, HERG channels are also modulated by PKC. The molecular mechanisms of this PKC-dependent process are not completely understood but do not depend on direct PKC-dependent phosphorylation of the channel.
class III antiarrhythmic agents [5] , and several class III receptor causes a shift in the HERG activation curve antiarrhythmic drugs such as dofetilide, amiodarone, towards more positive potentials, an effect that could be azimilide, or BRL-32872, act via inhibition of HERG mimicked by PMA [24] . Furthermore, coexpression of the potassium channels [4, [6] [7] [8] . Reduction of HERG currents a1A-adrenoceptor (a1C-adrenoceptor according to the old due to mutations in HERG or via excessive blockade by classification) [25] with HERG channels and stimulation antiarrhythmic or non-antiarrhythmic drugs produces chrowith the a1A-adrenergic agonist phenylephrine caused mosome 7-linked congenital long QT syndrome (LQTS-2) current reduction and a shift in the HERG activation curve and acquired long QT syndrome (LQTS), respectively in Xenopus oocytes [26] . [3, [9] [10] [11] [12] . Both forms of LQTS are associated with delayed
To elucidate the biochemical pathways of the putative cardiac repolarization, prolonged electrocardiographic QT PKC-dependent regulatory process in detail, we generated intervals and a high risk for the development of ventricular mutations of all 18 PKC-specific phosphorylation sites in 'torsade de pointes' arrhythmias and sudden cardiac death HERG to test for direct PKC-dependent phosphorylation of [13, 14] .
the HERG protein. The signal transduction mechanism was The clinical observation that patients with LQTS typiinvestigated by application of activators and inhibitors of cally develop arrhythmias during physical or emotional PKC and PKA. stress [15] suggests a link between adrenergic stimulation and HERG potassium channel activity. Recent studies have revealed that activation of the beta-adrenergic system and 2 . Methods consecutive elevation of the intracellular concentration of cAMP as second messenger regulates HERG channels 2 .1. Site-directed mutagenesis through protein kinase A-mediated phosphorylation of the channel protein and via direct interaction with the cAMP Consensus PKC phosphorylation sites with the amino binding site of HERG [16] [17] [18] [19] [20] . These effects are, at least acid sequence [Ser or Thr]-Xaa-[Arg or Lys] in HERG in part, mediated by the b1-adrenoceptor, as demonstrated were identified using PROSITE software. The program by Karle et al. [21] .
identified 18 sites in the HERG wild type protein. The In contrast, the influence of the alpha-adrenergic signal serine or threonine residues of the PKC phosphorylation transduction cascade on HERG currents is less well sites (S26, T74, T162, T174, S179, S250, S278, S354, understood. Adrenergic activity and subsequent stimulation T371, T526, S606, S636, T670, S890, T895, S918, S960, of the Gaq-protein coupled cardiac a1A-adrenoceptor and T1133) were replaced with alanine residues to elimicauses activation of the phosphatidyl inositol-specific nate PKC-mediated phosphorylation. This was performed phospholipase Cb (PLCb). Its substrate phosphatidyl-4,5-by site-directed mutagenesis with the QuikChange kit bisphosphate (PIP2), a membrane phospholipid, is hydro-(Stratagene, La Jolla, CA). The PCR products between lyzed to the intracellular second messengers 1,4,5-inositolunique anchor sites were sequenced (SeqLAB, Gottingen, trisphosphate (IP3) and diacylglycerol (DAG). IP3 leads to Germany), and fragments between unique restriction sites mobilization of intracellular calcium, and DAG is the were removed by use of the following combinations of physiological activator of protein kinase C (PKC), a restriction enzymes: Hind III, Nco I for S26A, T74A, serine-/ threonine-dependent kinase. The biochemical ac-T162A, T174A, S179A; Nco I, BstE II for S250A, S278A, tion of PKC is limited by the activity of the protein S354A, T371A; BstE II, Xho I for T526A, S606A, S636A, serine-/ threonine-phosphatases (PP) PP1, PP2A, and T670A; Xho I, FseI for S890A, T895A, S918A; and Fse I, PP2B. At least 10 isoforms of PKC have been identified BamH I for S960A and T1133A. The mutated fragments and grouped into three subtypes: conventional cPKCs (a, were ligated into the original HERG template and sebI, bII, g) that require calcium and / or DAG for activation; quenced again. To generate multiple residue mutants, novel nPKCs (d,´, h, u) that can be activated by DAG, but fragments with single mutations were cut out and sequenare insensitive to calcium; and atypical aPKCs (z, and tially subcloned into the respective templates, yielding the i / l), which are unresponsive to calcium or DAG [22] .
following four constructs: construct 1 (S26A, T74A, Under experimental conditions, phorbol esters can be used T162A, T174A, and T179A); construct 2 (S250A, S278A, to activate cPKC and nPKC isoforms by binding to the S354A, and T371A); construct 3 (T526A, S606A, S636A, cysteine-rich motifs of the protein, but they do not act on and T670A); construct 4 (S890A, T895A, S918A, S960A aPKC isoforms. and T1133A). The cDNAs of the constructs were verified We have previously demonstrated that phorbol 12-by sequencing. Electrophysiological measurements were myristate-13-acetate (PMA), a potent, but unspecific accarried out to probe for functional expression of the tivator of protein kinase C and other protein kinases, constructs in Xenopus oocytes. The constructs 2, 3, and 4 reduces HERG currents in guinea pig cardiomyocytes and displayed typical HERG potassium currents, whereas after Xenopus oocytes via an activation shift [23] . In the same expression of construct 1 no currents could be detected. We year, Barros et al. reported that thyreotropin releasing found that the T74A point mutation prevented the funchormone (TRH) and consecutive activation of the TRH tional expression of construct 1. Thus, we generated a construct 19, which lacks the T74A mutation. This clone was dissolved in DMSO to a stock solution of 100 mM could be expressed similar to the other constructs. The and stored at 220 8C. On the day of experiments, aliquots HERG DPKC clone lacking all functional PKC phosof the stock solution were diluted to the desired test phorylation sites (except T74) was generated by introconcentrations with the bath solution. All measurements ducing the restriction fragment with the mutations of were carried out at room temperature (20-22 8C HERG currents using a two-step protocol (see Fig. 1A ): A Each of the intermediate constructs and the HERG DPKC variable first step (test pulse) was recorded at different clone were verified by DNA sequencing.
potentials from 2100 to 180 mV (increment 10 mV) for 400 ms, followed by a second step to 2120 mV (400 ms) 2 .
Expression of HERG channels in Xenopus laevis
to measure inward tail currents. The holding potential was oocytes 280 mV. This protocol was used for all electrophysiological measurements performed in this study. The tail current Procedures for in vitro transcription and oocyte injection amplitude depends on the preceding test pulse potential have been published previously [16] . Briefly, cRNAs of and is a measure of channel activation. The activation HERG wild type [2] , minK [27] , hMiRP1 [28] , and the curves of HERG WT control currents had a mean half constructs generated in this study were prepared with the maximal activation voltage V of 23.564.9 mV (n529). 
.3. Electrophysiology and data analysis
The two-microelectrode voltage-clamp configuration was used to record currents from Xenopus laevis oocytes as described previously in detail [6] . Statistical data are expressed as mean6standard deviation (n5number of experiments). We used paired and unpaired Student's ttests to compare statistical significance of the results. A P-value,0.05 was considered to be statistically significant.
.4. Solutions and drug administration
Voltage clamp measurements of Xenopus oocytes were performed in a solution containing (in mM) 5 KCl, 100 NaCl, 1.5 CaCl , 2 MgCl , and 10 HEPES (pH 7.4). 2 2 Current and voltage electrodes were filled with 3 M KCl an unspecific protein kinase activator that stimulates tion voltage (DV ) to 3.564.1 mV (n55; Fig. 2A -C,G), (Table 1 , row B). In addition, preincubation with the PKC application of 100 nM PMA for 30 min). The maximum inhibitor bisindolylmaleimide I (1 and 10 mM) also outward current amplitude during the test pulse (at 0 mV) reduced the shift of the activation curve to 21.568.4 mV was reduced significantly by 55.5623.4% (n58). Fig. 1C (n57) and 20.262.6 mV (n54), respectively ( Fig. 2G ), displays the normalized and inverted tail current amand current decrease as well as deactivation time constants plitudes during the constant pulse as a function of the were significantly reduced or even abolished (Table 1 , preceding test pulse potentials, reflecting the activation rows C,D). The drugs used in this series of experiments curves (control measurement and recording after incubahave been previously shown to inhibit PKC under similar tion with 100 nM PMA for 30 min). The half maximal experimental conditions [24, 29, 30] . These results demonactivation voltage V was shifted by 31.268.4 mV from strate that HERG channels are regulated via protein kinase 1 / 2 23.564.9 to 27.768.7 mV (n529), which is the bio-C-dependent pathways (Fig. 2H) . To demonstrate the physical basis for the outward current reduction [23] . In effect of the PKC inhibitors Ro-32-0432 and bisinaddition, the peak tail current following the test pulse to 0 dolylmaleimide I in the absence of PMA, HERG currents mV was reduced by 63.8624.6% (n510), whereas maxiwere measured under control conditions (without preincumum peak tail currents were only reduced by 9.569.2% bation with PKC inhibitors) and after incubation with 3 (n510; Table 1 , row A). The reduction of the maximum mM Ro-32-0432 or 10 mM bisindolylmaleimide I (the peak tail currents was less pronounced compared to the maximum concentration used in this study) for 90 min. A reduction of peak tail currents measured after the 0-mV longer incubation time was not tolerated by the cells, pulse, since the shift of the activation curve by 31.2 mV which is most likely due to membrane damage by the still allows pronounced activation at very positive pomicroelectrodes. This approach revealed that Ro-32-0432 tentials. Furthermore, PMA treatment caused an accelera-( Table 2 , line A) caused weak reduction of HERG tail tion of the deactivation time constant, as illustrated by currents (following a 0-mV pulse), which is in line with faster tail current decay after PMA application (Fig. 1B) .
other control experiments ( ments. virtually not altered by Ro-32-0432. When bisinSince PMA is a rather unspecific protein kinase activator dolylmaleimide I (10 mM) was applied, the deactivation (Fig. 1D) , we examined whether specific inhibition of time constant was not significantly changed ( Table 2 , row protein kinases could reduce the effects caused by 100 nM B; n54), and the half-maximal activation voltage was only PMA (30 min). Pretreatment of oocytes with the specific shifted by 25.363.7 mV towards more negative potentials PKC inhibitor Ro-32-0432 (3 mM) for at least 4 h (n55). However, a pronounced tail current decrease by significantly reduced the shift of the half-maximal activa-51.469.4% (tail current after the 0-mV step; 90 min) and 
Data for inhibition of tail currents after the 0-mV pulse, maximum tail current reduction, and acceleration of the deactivation time constant are given as mean6S.D. (see text for details). Fig. 2 . The PMA-induced shift of the HERG WT activation curve is mediated by PKC and PKA. Panels A and D show typical control measurements. In panel A the oocyte was preincubated with the PKC inhibitor Ro-32-0432 (3 mM). After application of PMA together with 3 mM Ro-32-0432 or 2.5 mM of the PKA inhibitor KT 5720, the shift was abolished (Ro-32-0432, panel C; data obtained from panels A and B) or reduced to 3.1 mV (KT 5720, panel F; data obtained from panels D and E). G shows mean values for the shift caused by PMA application without pretreatment (PMA; n529) and after preincubation with 3 mM Ro-32-0432 (PMA1Ro; n55), 1 mM (n57) and 10 mM (n54) of the PKC inhibitor bisindolylmaleimide I (PMA11 B; PMA110 B), 100 mM of the broad range tyrosine kinase inhibitor genistein (PMA1Gen.; n54), and 10 mM wortmannin (PI3 kinase inhibitor, PMA1Wor.; n53), respectively. The mean values for DV after application of PMA in combination with 2.5 mM KT 5720 are displayed in (PMA1KT; 1 / 2 n57). H, putative action of PMA on HERG activation kinetics via PKC. Protocols and plots were identical to those shown in Fig. 1. 59.167.6% (maximum peak tail current; 90 min) occurred PMA (100 nM) for 30 min reduced both the activation rapidly upon drug application, reaching steady-state conshift (DV 51.264.7 mV; n57) and the tail current 1 / 2 ditions within 10 min. The rapid time course of this effect reduction ( Fig. 2D -F,G; Table 1 , row E), which is ( Table 2 , row B) indicates that this effect is most likely consistent with known PKA-dependent regulation of due to direct pharmacological inhibition of HERG cur-HERG activation [16] . However, the deactivation time rents. Pharmacological blockade of ether-a-go-go-related constant was still accelerated by PMA, indicating that the gene potassium channels by bisindolylmaleimide I has deactivation process is not PKA-dependent ( Table 1 , row A and Table 4 , row A), and the 3 .
The shift of the HERG activation curve is not deactivation time constant was markedly accelerated mediated by direct PKC-dependent phosphorylation of the HERG channel protein
To differentiate direct effects of protein kinase C on the channel protein from intermediate actions within the signal transduction cascade, we performed site-directed mutagenesis to generate mutated HERG channels that lack consensus PKC phosphorylation sites (S26, T74, T162, T174, S179, S250, S278, S354, T371, T526, S606, S636, T670, S890, T895, S918, S960, and T1133; Fig. 3 ). Four to five point mutations were combined in four different HERG constructs, and these clones were expressed in Xenopus oocytes to perform electrophysiological measurements (Table 3) . The constructs 2, 3, and 4 generated in this study resulted in functional potassium channels with biophysical properties similar to those of HERG WT. Values for half-maximal activation voltage under control conditions and the resulting shifts of the activation curves after application of 100 nM PMA (30 min) are given as mean6S.D.
(Table 4, row A). In the following set of experiments we
In these experiments, the HERG activation curve was only preincubated the oocytes expressing HERG DPKC chanshifted by 7.265.4 mV after addition of 100 nM PMA nels with Ro-32-0432 (3 mM) for at least 4 h prior to use.
(n55; Fig. 4D ). Simultaneous application of KT 5720 (2.5 n54; Fig. 4D ). Pretreatment with these drugs almost transduction proteins mediate this effect (Fig. 4E) . abolished the reduction of HERG tail currents (measured after the 0-mV step) caused by PMA application, and the deactivation time constants were markedly less accelerated 3 .
Specific activation of conventional PKC-isoforms by (Table 4, rows B,C). The intermediate constructs were
thymeleatoxin induces a shift in the HERG activation investigated as well. As displayed in Table 2 , the baseline curve independently of direct channel phosphorylation by midpoints in the activation curves were more negative in PKC constructs 3 and 4 compared to HERG WT channels. The activation shift caused by PMA was attenuated in construct
To investigate the role of protein kinase C in the 3. Other parameters were not markedly different from regulation of HERG current activation in more detail, we HERG WT channels. These results illustrate that PMA examined the acute effects of the specific cPKC activator does not act via direct PKC-dependent channel phosthymeleatoxin (Fig. 5 , Table 5 ). When 100 nM 
Data for inhibition of tail currents after the 0-mV pulse, maximum tail current reduction, and acceleration of the deactivation time constant are given as mean6S.D. (see text for details).
thymeleatoxin was applied into the bath for 60 min, the type activation kinetics, we preincubated oocytes for 4-9 h activation curve of HERG WT was shifted by 24.567. 9 with cytoskeletal modifying agents and examined the mV from 23.563.6 to 20.968.5 mV (n511), HERG tail response to 100 nM PMA. First, we applied cytochalasin B currents following the 0-mV pulse were reduced, and the (1 mM), a compound that inhibits the polymerization of deactivation time constant was accelerated ( Table 5, row actin monomers to actin filaments. The half-maximal A). Thus, it is likely that conventional PKC isoforms act activation voltage after the preincubation period was not on HERG currents, since the PMA-mediated effects were significantly altered compared to non-incubated oocytes mimicked by the cPKC activator thymeleatoxin. Further-(23.361.6 mV), and 100 nM PMA (30 min) caused a shift more, it was investigated whether thymeleatoxin acts via of the activation curve of 37.266.3 mV (n55). In addition, PKC-dependent HERG channel phosphorylation. pretreatment of oocytes with colchicine (10 mM), an agent Thymeleatoxin caused a HERG DPKC activation curve that disrupts microtubules, had no effect on V under tion time constant under the same experimental conditions mV (n58). This value was not significantly different from as described above (Table 5 , row B), suggesting that the the shift induced by PMA alone (31.2 mV). Moreover, thymeleatoxin-induced activation shift caused by activation values for tail current reduction (measured after the 0-mV of cPKC isoforms is not mediated by direct PKC-depenstep) and deactivation time constant acceleration obtained dent phosphorylation of the HERG channel protein (Fig. after preincubation with cytochalasin B (Table 6 , row A) 5E).
or colchicine (Table 6 , row B) were similar compared to experiments where PMA was applied without additional 3 .4. Characterization of the intracellular environment drugs (Table 1 , row A). Thus, the regulation of HERG required for the PMA-induced HERG activation shift currents by PMA is not significantly modulated by cytoskeleton integrity. Cytoskeletal actin filaments or microtubules might Finally, we coexpressed HERG wild type (WT) chan-1 modulate the HERG activation shift via localization of nels with the regulatory b-subunits minK (minimal K PKC and the putative additional factors to their respective channel) [27] and hMiRP1 (human minK-related peptide substrates (including HERG) or anchoring proteins, as it 1) [28] . Under control conditions, the half maximal was observed in the regulation of Kv1.5 channels by activation voltage did not differ markedly from HERG WT protein kinases [40] . To elucidate the role of the cytochannels (26.361.4 mV for minK, and 27.861.6 mV for skeleton in the PMA-induced modulation of HERG wild hMiRP1, respectively). After incubation with 100 nM T able 6 Effects of various factors modulating the intracellular environment on the PMA-induced HERG WT current modulation 
PMA for 30 min, V was shifted by 32.463.2 mV (n54; on HERG channels could be mimicked by the specific 1 / 2 minK) and 29.469.4 mV (n57; hMiRP1). Furthermore, cPKC activator thymeleatoxin, demonstrating that conventail currents following the 0-mV step were reduced and tional PKC isoforms are involved in the regulatory mechadeactivation time constants were accelerated largely siminism. It is reasonable to assume that additional interlar to experiments with PMA alone (Table 6, rows C,D; mediate signal transduction proteins mediate the effect, Table 1 , row A). Thus, neither minK nor hMiRP1 caused since direct PKC-dependent phosphorylation is not inpronounced changes in HERG current regulation by PMA.
volved. The time course of PMA to cause (ion channel) phosphorylation can be obtained from a study by Karle et al. [41] . Kir2.1b potassium currents expressed in Xenopus 4 . Discussion oocytes were inhibited by 100 nM PMA with relatively slow onset, and maximum block was reached after 30 min. In the present study, we investigated the effects of This effect was due to direct PKC-dependent channel protein kinase C activation on HERG currents. The results phosphorylation, since after mutagenesis of the PKC of the present study imply a novel pathway of HERG phosphorylation sites in Kir2.1b the PMA-induced effect channel regulation by protein kinase C independently of was completely abolished. Thus, we may speculate that direct phosphorylation of the channel protein (Fig. 6A) , in PMA exerts its (indirect) effects on HERG currents via addition to known PKA-dependent pathways involving PKC-dependent phosphorylation of intermediate factors / direct HERG channel phosphorylation (Fig. 6B) [16, 18] .
proteins, since the time course of the PMA-effects on This was demonstrated by comparing the action of protein HERG currents observed in this study are similar (30 min). kinase activators and specific protein kinase inhibitors on
The putative intermediate factors might consecutively act HERG wild type channels with their effects on mutant on HERG channels with rapid time course. Moreover, HERG DPKC channels lacking PKC-dependent phos-PMA is likely to act via PKC-dependent pathways, since phorylation sites.
the effect could be attenuated by PKC inhibitors. However, One important finding of this study is the involvement in contrast to PMA, there are no studies investigating of PKC in the complex mechanism by which HERG precisely the time course of PKC inhibition by these PKC channel activation kinetics are modulated. In the presence inhibitors. Therefore, we have to adhere to the indirect of the unspecific protein kinase activator PMA, the HERG conclusions that can be obtained from previous studies wild type activation curve was shifted, HERG tail currents [24, 29, 30] . These data demonstrate that in general preincu-(measured after a 0-mV voltage step) were reduced and the bation for several hours is necessary to achieve prodeactivation was accelerated. Preincubation with PKC nounced inhibition of PKC activity by Ro-32-0432 and inhibitors markedly attenuated this effect, suggesting a role bisindolylmaleimide I. Furthermore, bisindolylmaleimide I of protein kinase C in the regulation of HERG currents. We did not significantly block the PMA-induced effect when also investigated the significance of putative direct channel the drugs were applied simultaneously without preincubaphosphorylation by protein kinase C. The activation and tion with the PKC inhibitor [23] . Thus, it is likely that the deactivation kinetics as well as current amplitudes of time courses of PKC inhibition and block of the PMAmutant HERG channels lacking PKC-dependent phosinduced effect do not differ. The hypothesis that PMA as phorylation sites (HERG DPKC) were still modulated by well as the PKC inhibitors act through PKC modulation PMA, indicating that PKC does not act via direct phos-(although independently of direct HERG protein phosphorylation of HERG channel proteins at the PKC consenphorylation) is further supported by the following aspects. sus sites (Fig. 6A) . Furthermore, the PMA-induced effect First, previous studies have shown that PMA activates protein kinase C in Xenopus oocytes [24, 37, 39, [41] [42] [43] [44] . Second, specific inhibition of PKC in Xenopus oocytes by bisindolylmaleimide I [24] and by Ro-32-0432 [29] has been demonstrated previously. Third, application of the specific cPKC activator thymeleatoxin mimicked the PMA effects. In summary, it is concluded that the PMA-induced effects are mediated through protein kinase C activation. Protein kinase C-dependent modulation of multiple cardiac ion channels has been investigated before, revealing that in most cases the regulatory mechanism involves direct phosphorylation of the channel (Table 7) . There are, however, few ion currents where PKC does not act directly initial current increase and subsequent current reduction phosphorylation, whereas PKA phosphorylates the channel protein directly [16] , thereby inducing an activation shift. [45] . This effect can be modulated by protein kinase A in an additive manner, i.e. activation of PKA and subsequent HERG channels observed in this study could be caused by current increase prevents additional PKC dependent efadrenergic stimulation under physiological and fects, and vice versa. To date, the molecular mechanism of pathophysiological conditions in the human heart. Under in minK regulation by PKC is not completely clear, but it is vitro conditions, coexpression of HERG channels and speculated that multiple phosphorylation sites are involved.
a1A-adrenoceptors in Xenopus oocytes and consecutive In the present study, all PKC-dependent phosphorylation receptor stimulation with phenylephrine was shown to sites in HERG have been eliminated except for T74, cause a shift of V towards more positive potentials [26] . 1 / 2 because the T74A mutation prevented channel expression Furthermore, in HEK 293 cells expressing HERG and and functional electrophysiological studies. Thus, although a1A-adrenoceptors, a-adrenergic stimulation led to a 17 phosphorylation sites were not functionally relevant, we significant current decrease and a small depolarizing shift cannot totally exclude that the remaining T74 site is in the voltage dependence of activation [52] . responsible for the PKC-dependent HERG current modulaIn summary, we could demonstrate that HERG channel tion. Secondly, the investigation of Kv1.5 regulation activation is modulated by activation of protein kinase C in revealed that PKC primarily phosphorylates the accessory addition to known direct PKA-dependent phosphorylation. channel subunit Kvb1.2, thereby reducing Kv1.5 currents Direct phosphorylation of the channel protein by protein [44] . In the present study, neither of the putative regulatory kinase C is not involved in this novel PKC-dependent HERG subunits minK and hMiRP1 significantly modulated regulatory mechanism (Fig. 6 ). Further investigations are the PMA effect. Thus, these proteins can be ruled out as necessary to elucidate cell type specific factors that moduintermediate factors mediating the PKC-induced HERG late this pathway, and to identify putative intermediate activation shift. In addition, based on our results, neither proteins mediating the effect. actin filaments nor microtubules seem to be of functional relevance, as demonstrated for the modulation of Kv1.5 by protein kinase A [40] .
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